ARMISTICE CAPITAL, LLC
Registered adviserFiling Date
Global Rank
#625
/ 8,818
▲ 113
Top Industry
Biotechnology
47.4%
Period ended 4 months ago
Filed Aug 14, 2026 · 2mo
26 quarters · since Mar 2020
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Holder type
Registered adviser
Form ADV roster, Oct 1, 2026
Regulatory AUM
$4,724,705,592
Main clients
Pooled investment vehicles
(100% of AUM)
Private funds
1 fund
· Hedge funds
Focus by fund count, roster of Oct 1, 2026
$4,724,705,592 gross assets
LEI
549300KF4D500QMUP976
Private funds on Schedule D 7.B.(1)
As filed May 31, 2024; SEC's bulk Form ADV archive ends with 2024 filings.
$5,911,150,000 gross assets in 1 fund
Hedge funds
$5,911,150,000
(1)
Form ADV history
Monthly rosters from Dec 2019; each row is a run with the same figures, newest first.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Apr 2026 to Oct 2026 | $4,724,705,592 | Pooled investment vehicles (100%) |
| Apr 2025 to Mar 2026 | $5,542,954,924 | Pooled investment vehicles (100%) |
| Apr 2024 to Mar 2025 | $5,911,150,000 | Pooled investment vehicles (100%) |
| May 2023 to Mar 2024 | $5,555,432,880 | Pooled investment vehicles (100%) |
| Apr 2023 | $5,555,432,880 | Pooled investment vehicles (100%) |
| Apr 2022 to Mar 2023 | $5,499,394,945 | Pooled investment vehicles (100%) |
3 earlier changes not shown.
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Style
Diversified active
Top 10 weight 27.4%, 71.1 effective positions, active share 88.1% against every 13F filer's combined book; it meets none of the index-like, systematic-like or concentrated tests
Turnover
Medium turnover
84.0% over the last four quarters (30% to under 100%)
Horizon
Horizon unknown
The value-weighted holding period is at least 11.5 quarters, but 15.5% of the book was already held when coverage starts
Closest benchmark: every 13F filer's combined book, active share 88.1%; sector active share 59.0% against the combined 13F book's sector weights.
Over time 26 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
324 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
29.2%
+5.0 pts
Top 5
57.7%
+8.3 pts
Top 10
65.0%
+4.7 pts
HHI
1,353
Diversified+449
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 50.6% | $4,139,648,429 |
| Healthcare | 34.9% | $2,851,170,138 |
| Technology | 7.0% | $575,511,079 |
| Consumer Cyclical | 3.4% | $279,487,513 |
| Communication Services | 1.9% | $152,941,742 |
| Consumer Defensive | 1.4% | $117,147,541 |
| Industrials | 0.5% | $42,425,195 |
| Financial Services | 0.1% | $4,414,080 |
| Real Estate | 0.0% | $3,775,320 |
| Basic Materials | 0.0% | $3,051,306 |
| Energy | 0.0% | $2,857,328 |
| Utilities | 0.0% | $964,089 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VSTM | Verastem, Inc. | +2,432,000 | 7,024,000 | $26,831,680 | |
| NTLA | Intellia Therapeutics, Inc. | +1,164,000 | 1,500,000 | $25,380,000 | |
| SLDB | Solid Biosciences Inc. | +1,078,000 | 4,278,000 | $42,737,220 | |
| ZETA | Zeta Global Holdings Corp. | +954,276 | 965,273 | $18,996,572 | |
| ARVN | Arvinas, Inc. | +818,000 | 2,796,000 | $23,234,760 | |
| SNY | Sanofi | +764,000 | 1,064,000 | $45,390,240 | |
| PWCM | Powercompute, Inc. | +761,904 | 1,859,057 | $276,999 | |
| SUPN | Supernus Pharmaceuticals, Inc. | +750,854 | 2,646,201 | $123,074,808 | |
| PATH | UiPath, Inc. | +715,280 | 2,000,000 | $21,740,000 | |
| XRAY | DENTSPLY SIRONA Inc. | +672,000 | 3,672,000 | $38,959,920 | |
| VSEED | Vsee Health, Inc. | +580,902 | 4,079,129 | $471,547 | |
| OFIX | Orthofix Medical Inc. | +564,000 | 3,264,000 | $29,832,960 | |
| MLYS | Mineralys Therapeutics, Inc. | +560,000 | 1,736,000 | $46,837,280 | |
| CYTK | Cytokinetics Inc | +436,804 | 1,201,342 | $102,342,324 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | +436,000 | 1,764,000 | $13,441,680 | |
| RIGL | Rigel Pharmaceuticals Inc | +392,000 | 1,672,000 | $65,408,640 | |
| ANGO | Angiodynamics Inc | +329,000 | 2,198,000 | $28,595,980 | |
| SFIX | Stitch Fix, Inc. | +315,254 | 352,776 | $1,449,909 | |
| NUVB | Nuvation Bio Inc. | +264,000 | 2,000,000 | $11,360,000 | |
| INCY | Incyte Corp | +243,188 | 900,005 | $102,024,566 | |
| IMCR | Immunocore Holdings plc | +240,000 | 1,428,000 | $45,339,000 | |
| TOST | Toast, Inc. | +233,359 | 810,830 | $22,557,290 | |
| CPRI | Capri Holdings Ltd | +178,000 | 836,000 | $15,524,520 | |
| FRPT | Freshpet, Inc. | +167,395 | 1,260,702 | $74,532,702 | |
| HNST | Honest Company, Inc. | +154,658 | 175,900 | $643,794 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ERNAW | Ernexa Therapeutics Inc. | −3,840,000 | 160,000 | $11,408 | |
| TVTX | Travere Therapeutics, Inc. | −3,324,878 | 1,572,539 | $89,335,940 | |
| IMVT | Immunovant, Inc. | −1,828,916 | 1,736,000 | $66,888,080 | |
| IRWD | Ironwood Pharmaceuticals Inc | −1,096,000 | 13,932,000 | $58,653,720 | |
| MGNX | Macrogenics Inc | −1,005,248 | 5,006,752 | $23,131,194 | |
| PTCT | Ptc Therapeutics, Inc. | −1,003,054 | 1,071,395 | $87,393,690 | |
| PENN | PENN Entertainment, Inc. | −906,000 | 672,000 | $14,353,920 | |
| AUTL | Autolus Therapeutics plc | −800,000 | 15,000,000 | $24,000,000 | |
| S | SentinelOne, Inc. | −692,188 | 1,205,661 | $20,460,067 | |
| CTOR | Citius Oncology, Inc. | −483,266 | 8,705,589 | $5,658,632 | |
| AGIO | Agios Pharmaceuticals, Inc. | −316,000 | 2,400,000 | $89,064,000 | |
| NTRP | NextTrip, Inc. | −273,036 | 402,081 | $860,453 | |
| IMNN | Imunon, Inc. | −203,563 | 144,767 | $257,685 | |
| BILL | BILL Holdings, Inc. | −193,291 | 181,617 | $6,567,270 | |
| NBIX | Neurocrine Biosciences Inc | −188,162 | 535,838 | $90,310,136 | |
| DDOG | Datadog, Inc. | −170,885 | 37,679 | $9,810,104 | |
| AXGN | Axogen, Inc. | −161,000 | 775,000 | $35,797,250 | |
| DWTX | Dogwood Therapeutics, Inc. | −147,514 | 3,132,486 | $5,043,302 | |
| EW | Edwards Lifesciences Corp | −126,917 | 97,918 | $8,857,662 | |
| ESLA | Estrella Immunopharma, Inc. | −123,780 | 3,975,220 | $4,134,228 | |
| INGN | Inogen Inc | −104,000 | 1,096,000 | $7,069,200 | |
| INTC | Intel Corp | −94,984 | 129,011 | $18,013,805 | |
| VRCA | Verrica Pharmaceuticals Inc. | −91,877 | 426,304 | $2,608,980 | |
| DYN | Dyne Therapeutics, Inc. | −87,884 | 3,087,226 | $68,567,289 | |
| BDRX | Biodexa Pharmaceuticals Plc | −82,712 | 14,809 | $43,094 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| WAT | Waters Corp | 75,004 | $28,129,500 | |
| ILMN | Illumina, Inc. | 91,118 | $16,021,277 | |
| PBH | Prestige Consumer Healthcare Inc. | 336,000 | $15,882,720 | |
| FWONK | Liberty Media Corp | 165,106 | $15,708,184 | |
| ITGR | Integer Holdings Corp | 167,746 | $15,675,863 | |
| LYV | Live Nation Entertainment, Inc. | 81,824 | $14,982,792 | |
| NVO | Novo Nordisk A S | 312,000 | $14,957,280 | |
| TWST | Twist Bioscience Corp | 142,000 | $14,608,960 | |
| TTWO | Take Two Interactive Software Inc | 49,877 | $12,468,252 | |
| MRVL | Marvell Technology, Inc. | 39,978 | $11,909,046 | |
| BSX | Boston Scientific Corp | 265,201 | $11,318,778 | |
| NOK | Nokia Corp | 849,701 | $11,284,029 | |
| NTSK | Netskope Inc | 1,000,000 | $10,940,000 | |
| FOXA | Fox Corp | 202,892 | $10,582,846 | |
| SHAK | Shake Shack Inc. | 183,118 | $10,258,270 | |
| ARMK | Aramark | 136,000 | $7,738,400 | |
| SBUX | Starbucks Corp | 68,089 | $6,958,014 | |
| XRT | State Street(R) SPDR(R) S&P(R) Retail ETF | 78,787 | $6,912,771 | |
| APPN | Appian Corp | 300,000 | $6,870,000 | |
| RPID | Rapid Micro Biosystems, Inc. | 3,328,000 | $5,757,440 | |
| RTB | RTB Digital, Inc. | 350,000 | $5,278,000 | |
| LIVN | LivaNova PLC | 58,451 | $4,806,425 | |
| BTSG | BrightSpring Health Services, Inc. | 63,409 | $4,422,143 | |
| MCK | Mckesson Corp | 5,551 | $4,194,335 | |
| CRMD | CorMedix Inc. | 500,000 | $3,925,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| — | 2,000,000 | $28,020,000 | ||
| MDLN | Medline Inc. | 564,857 | $25,136,136 | |
| — | 1,236,000 | $24,880,680 | ||
| ENR | Energizer Holdings, Inc. | 1,200,000 | $19,704,000 | |
| META | Meta Platforms, Inc. | 32,594 | $18,648,005 | |
| — | 3,930,125 | $10,768,543 | ||
| IQV | Iqvia Holdings Inc. | 60,884 | $10,383,157 | |
| SGMOQ | Sangamo Therapeutics, Inc | 40,400,067 | $10,100,016 | |
| GEHC | GE HealthCare Technologies Inc. | 118,289 | $8,419,811 | |
| TENX | Tenax Therapeutics, Inc. | 478,827 | $7,656,443 | |
| NVST | Envista Holdings Corp | 264,008 | $6,697,882 | |
| ICLR | Icon PLC | 60,268 | $6,669,256 | |
| DVA | Davita Inc. | 42,978 | $6,605,288 | |
| LCTX | Lineage Cell Therapeutics, Inc. | 3,182,799 | $5,028,822 | |
| AS | Amer Sports, Inc. | 148,770 | $4,897,508 | |
| PRTA | Prothena Corp Public Ltd Co | 439,411 | $4,271,074 | |
| KEYS | Keysight Technologies, Inc. | 14,717 | $4,155,639 | |
| MTSI | MACOM Technology Solutions Holdings, Inc. | 16,808 | $3,732,552 | |
| MCD | Mcdonalds Corp | 11,527 | $3,582,476 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 364,000 | $3,417,960 | |
| FIX | Comfort Systems USA Inc | 2,356 | $3,248,900 | |
| AMD | Advanced Micro Devices Inc | 15,600 | $3,173,508 | |
| CIEN | Ciena Corp | 8,140 | $3,160,192 | |
| ONTO | Onto Innovation Inc. | 13,921 | $2,854,779 | |
| VSXY | Victoria's Secret & Co. | 55,693 | $2,581,927 | |
| No positions match the current search. | ||||
324 tracked positions ·
$8,173,393,760 total
· filing declares
341 positions · $8,173,736,250
· as of Jun 30, 2026
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Showing 1–50
of 324 positions by value
· page 1 of 7
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
PUT
|
Added | 3,200,000 | $2,389,664,000 | 29.24% | |
| IWM |
iShares Russell 2000 ETF
PUT
|
Added | 5,800,000 | $1,742,610,000 | 21.32% | |
| CYTK |
Cytokinetics Inc
CALL
+ SHARES
Healthcare
|
Added | 2,731,342 | $232,683,024 | 2.85% | |
| AGIO |
Agios Pharmaceuticals, Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 5,210,000 | $193,343,100 | 2.37% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 288,000 | $154,641,600 | 1.89% | |
| PTCT |
Ptc Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 1,731,395 | $141,229,890 | 1.73% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
Added | 2,646,201 | $123,074,808 | 1.51% | |
| TVTX |
Travere Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 2,072,539 | $117,740,940 | 1.44% | |
| IMVT |
Immunovant, Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 2,936,000 | $113,124,080 | 1.38% | |
| INCY |
Incyte Corp
Healthcare
|
Added | 900,005 | $102,024,566 | 1.25% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 535,838 | $90,310,136 | 1.10% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 183,000 | $76,060,290 | 0.93% | |
| MLYS |
Mineralys Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
Added | 2,776,000 | $74,896,480 | 0.92% | |
| FRPT |
Freshpet, Inc.
Consumer Defensive
|
Added | 1,260,702 | $74,532,702 | 0.91% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 3,087,226 | $68,567,289 | 0.84% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
Added | 284,562 | $67,822,507 | 0.83% | |
| RIGL |
Rigel Pharmaceuticals Inc
Healthcare
|
Added | 1,672,000 | $65,408,640 | 0.80% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 122,480 | $61,406,572 | 0.75% | |
| IRWD |
Ironwood Pharmaceuticals Inc
Healthcare
|
Reduced | 13,932,000 | $58,653,720 | 0.72% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
Reduced | 1,564,000 | $56,945,240 | 0.70% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Added | 89,809 | $55,999,503 | 0.69% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 724,000 | $50,542,440 | 0.62% | |
| S |
SentinelOne, Inc.
CALL
+ SHARES
Technology
|
Reduced | 2,805,661 | $47,612,067 | 0.58% | |
| SNY |
Sanofi
Healthcare
|
Added | 1,064,000 | $45,390,240 | 0.56% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Added | 1,428,000 | $45,339,000 | 0.55% | |
| GOOGL |
Alphabet Inc.
Communication Services
|
Added | 126,494 | $45,205,160 | 0.55% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Added | 4,278,000 | $42,737,220 | 0.52% | |
| MDB |
MongoDB, Inc.
Technology
|
Added | 125,172 | $42,045,274 | 0.51% | |
| GTLB |
Gitlab Inc.
CALL
+ SHARES
Technology
|
Added | 1,344,141 | $41,036,624 | 0.50% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Reduced | 3,678,000 | $40,347,660 | 0.49% | |
| XRAY |
DENTSPLY SIRONA Inc.
Healthcare
|
Added | 3,672,000 | $38,959,920 | 0.48% | |
| UBER |
Uber Technologies, Inc
Technology
|
Reduced | 497,908 | $35,929,041 | 0.44% | |
| AXGN |
Axogen, Inc.
Healthcare
|
Reduced | 775,000 | $35,797,250 | 0.44% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 460,000 | $33,644,400 | 0.41% | |
| FIVN |
Five9, Inc.
Technology
|
Reduced | 1,536,000 | $32,747,520 | 0.40% | |
| HUBS |
Hubspot Inc
Technology
|
Added | 178,047 | $32,495,357 | 0.40% | |
| ALGN |
Align Technology Inc
Healthcare
|
Added | 180,286 | $30,407,036 | 0.37% | |
| MSFT |
Microsoft Corp
Technology
|
Added | 80,581 | $30,058,324 | 0.37% | |
| OFIX |
Orthofix Medical Inc.
Healthcare
|
Added | 3,264,000 | $29,832,960 | 0.37% | |
| HUM |
Humana Inc
Healthcare
|
Reduced | 72,527 | $28,809,174 | 0.35% | |
| ANGO |
Angiodynamics Inc
Healthcare
|
Added | 2,198,000 | $28,595,980 | 0.35% | |
| WAT |
Waters Corp
Healthcare
|
NEW | 75,004 | $28,129,500 | 0.34% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Added | 7,024,000 | $26,831,680 | 0.33% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Held | 2,000,000 | $26,600,000 | 0.33% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
Added | 1,500,000 | $25,380,000 | 0.31% | |
| WYNN |
Wynn Resorts Ltd
Consumer Cyclical
|
Added | 261,065 | $25,346,800 | 0.31% | |
| TMCI |
Treace Medical Concepts, Inc.
Healthcare
|
Held | 6,364,000 | $25,328,720 | 0.31% | |
| AUTL |
Autolus Therapeutics plc
Healthcare
|
Reduced | 15,000,000 | $24,000,000 | 0.29% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Added | 2,796,000 | $23,234,760 | 0.28% | |
| MGNX |
Macrogenics Inc
Healthcare
|
Reduced | 5,006,752 | $23,131,194 | 0.28% |
Showing the top 50 of 324 positions. Create a free account to see every position, past quarters, search, filters and CSV export.
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.